antibodi
reject
often
accompani
nondonor
hla
specif
antibodi
ndsa
selfreact
antibodi
develop
alongsid
donorspecif
antibodi
dsa
determin
sourc
antibodi
immort
b
cell
clone
kidney
transplant
recipi
humor
reject
two
clone
react
hla
class
mica
clone
also
reactiv
self
antigen
lysat
kidney
cell
line
henc
reveal
pattern
polyreact
monoclon
verifi
identif
singl
rearrang
immunoglobulin
heavi
chain
variabl
region
vh
sequenc
clone
track
uniqu
sequenc
found
one
polyreact
clone
highli
expand
patient
blood
repres
circul
b
cell
vh
sequenc
clone
show
evid
somat
mutat
consist
memori
phenotyp
expans
lastli
reactiv
expand
polyreact
b
cell
clone
found
patient
serum
time
reject
conclus
provid
proof
principl
clonal
level
human
antibodi
crossreact
hla
self
find
strongli
suggest
polyreact
antibodi
contribut
dsa
ndsa
well
autoantibodi
transplant
recipi
antibodi
reactiv
kidney
graft
implic
transplant
reject
year
yet
much
remain
elucid
regard
gener
fine
specif
function
main
target
humor
respons
hla
class
class
ii
molecul
express
donor
cell
mismatch
recipi
antigen
recogn
nonself
host
immun
system
due
polymorph
allel
determin
lead
gener
donor
specif
antibodi
dsa
serolog
respons
target
also
report
follow
kidney
transplant
includ
nondonor
specif
antibodi
ndsa
ie
antibodi
reactiv
hla
molecul
express
donor
cell
ndsa
develop
still
uncertain
wide
accept
explan
ndsa
dsa
crossreact
public
epitop
share
multipl
hla
instanc
especi
absenc
dsa
gener
ndsa
thought
result
previou
exposur
nondonor
hla
exampl
via
blood
transfus
pregnanc
abund
literatur
also
attest
develop
antibodi
selfantigen
alongsid
antihla
antibodi
transplant
recipi
recent
studi
use
combin
solid
phase
techniqu
includ
protein
microarray
character
serolog
profil
kidney
transplant
recipi
chronic
humor
reject
chr
experi
show
patient
sera
react
numer
autoantigen
time
chr
moreov
serum
reactiv
pattern
appear
remark
uniqu
individu
minim
overlap
patient
complex
serolog
respons
combin
allogen
autoimmun
compon
intrigu
difficult
explain
present
studi
investig
antibodi
respons
associ
graft
reject
cellular
level
isol
clone
character
b
cell
respons
product
graft
reactiv
antibodi
examin
natur
antibodi
look
possibl
relat
alloand
autoreact
patient
studi
report
year
old
male
underw
explant
second
kidney
transplant
consecut
reject
origin
diseas
focal
segment
glomerulosclerosi
fsg
first
kidney
fail
year
initi
transplant
consecut
cyclosporin
vasculopathi
focal
acut
cellular
reject
second
kidney
graft
transplant
year
reject
first
one
function
year
remov
suspect
pyelonephr
section
nephrectomi
specimen
show
dens
mononuclear
inflammatori
cell
infiltr
mark
tubul
interstiti
hemorrhag
infiltr
contain
focal
aggreg
neutrophil
stain
neg
peritubular
glomerular
capillari
summari
nephrectomi
show
acut
cellular
reject
type
iii
superimpos
chronic
reject
patient
slight
posit
cmv
serolog
month
posttranspl
serolog
becam
neg
month
treatment
patient
receiv
blood
transfus
year
prior
second
transplant
hla
type
blood
donor
document
hla
type
patient
donor
follow
recipi
donor
nd
kidney
donor
st
kidney
anticlass
class
ii
antibodi
detect
low
level
second
transplant
reactiv
class
class
ii
significantli
higher
time
nephrectomi
collect
clinic
specimen
medic
inform
use
studi
approv
massachusett
gener
hospit
intern
review
board
multipl
fragment
explant
kidney
graft
dissoci
mechan
obtain
cell
suspens
although
graft
specimen
thoroughli
rins
pb
blood
still
present
tissu
time
dissoci
mononuclear
cell
isol
cell
suspens
gradient
centrifug
ficollpaqu
plu
ge
healthcar
piscataway
nj
ebvtransform
b
cell
clone
gener
incub
immunopurifi
b
cell
microbead
miltenyi
biotec
auburn
ca
supernat
ebvproduc
marmoset
cell
presenc
agonist
cpg
limit
dilut
clone
perform
well
plate
plate
serial
dilut
cell
top
feeder
cell
consist
irradi
monocyt
cell
per
well
well
plate
establish
clone
maintain
rpmi
supplement
heatinactiv
fetal
bovin
serum
mm
glutamin
mm
sodium
pyruv
mm
hepe
antibiot
cell
grow
plate
less
well
contain
grow
cell
presum
clonal
clonal
confirm
molecular
analysi
ig
heavi
chain
transcript
describ
reactiv
b
cell
clone
supernat
well
patient
serum
sampl
hla
molecul
assess
use
bead
coat
either
mix
hla
molecul
labscreen
mix
one
lambda
lo
angel
ca
singl
hla
molecul
labscreen
singl
antigen
hla
class
class
ii
one
lambda
antibodi
reactiv
bead
detect
antiigg
one
lambda
igm
invitrogen
carlsbad
ca
peconjug
secondari
antibodi
luminex
apparatu
luminex
austin
tx
elisa
assay
detect
antibodi
doubl
strand
dna
dsdna
whole
protein
extract
human
embryon
kidney
cell
line
insulin
perform
previous
describ
antibodi
bind
reveal
hrpconjug
goat
antihuman
iggma
invitrogen
develop
use
tmb
sigmaaldrich
optic
densiti
read
nm
slide
coat
cell
bion
enterpris
ltd
de
plain
il
incub
room
temperatur
serum
sampl
dilut
undilut
clone
supernat
min
wash
pb
stain
fluorescein
isothiocyanateconjug
antihuman
igg
igmiga
invitrogen
wash
pb
visual
fluoresc
microscopi
total
rna
extract
immort
clone
use
trizol
reagent
invitrogen
superscript
iii
revers
transcriptas
kit
invitrogen
use
gener
cdna
variabl
region
ig
heavi
chain
amplifi
pcr
use
familyspecif
forward
primer
consensu
jh
revers
primer
figur
pcr
condit
follow
cycl
pcr
product
clone
ta
vector
invitrogen
use
transform
chemic
compet
bacteria
invitrogen
twenti
repres
coloni
per
clone
harvest
sequenc
use
correspond
vh
primer
confirm
clonal
b
cell
sequenc
done
massachusett
gener
hospit
dna
core
facil
immort
b
cell
clone
stain
peconjug
antibodi
bd
bioscienc
wash
analyz
use
facscan
flow
cytomet
bd
bioscienc
assess
origin
immort
b
cell
clone
donorand
recipientderiv
ebv
cell
line
stain
fitcconjug
antibodi
biolegend
san
diego
ca
wash
analyz
use
accuri
flow
cytomet
bd
bioscienc
total
rna
extract
patient
pbmc
collect
time
nephrectomi
well
graft
tissu
use
trizol
reagent
invitrogen
firststrand
cdna
synthes
superscript
iii
revers
transcriptas
kit
invitrogen
vh
region
correspond
clone
studi
clone
clone
clone
figur
amplifi
pcr
use
cdna
blood
graft
origin
follow
method
describ
pcr
product
clone
topo
ta
vector
invitrogen
use
transform
chemic
compet
bacteria
invitrogen
pcr
product
individu
coloni
screen
hybrid
presenc
plasmid
contain
vh
insert
well
correspond
clonespecif
sequenc
strategi
depict
figur
dotblot
techniqu
use
wellplat
vacuum
manifold
system
spot
nylon
membran
brightstar
plu
ambion
austin
tx
plasmid
dna
sampl
correspond
singl
coloni
one
posit
control
dot
plasmid
dna
contain
vh
segment
correspond
clone
one
neg
control
empti
well
present
plate
membran
sequenti
hybrid
first
plabel
clonotyp
probe
correspond
uniqu
region
clone
figur
plabel
jh
consensu
probe
detect
presenc
vh
insert
dna
sampl
show
posit
hybrid
signal
clonotyp
probe
sequenc
confirm
presenc
uniqu
clonal
sequenc
result
report
ratio
confirm
clonal
specif
dot
total
number
vh
chain
posit
dot
character
cell
respons
humor
respons
kidney
allograft
gener
seri
immort
b
cell
clone
start
patient
underw
transplant
nephrectomi
acut
chronic
antibodi
mediat
reject
b
cell
immunopurifi
explant
graft
tissu
immort
ebv
one
hundr
seven
clone
gener
propag
vitro
initi
sampl
clone
produc
igg
igm
cultur
use
antibodi
secret
cultur
supernat
determin
specif
correspond
b
cell
cultur
supernat
immort
b
cell
clone
assess
hla
reactiv
class
class
ii
mica
antigen
luminex
use
bead
coat
multipl
molecul
shown
figur
one
clone
produc
igm
reactiv
mica
one
clone
produc
igm
igg
reactiv
class
molecul
character
specif
igm
igg
produc
assess
reactiv
individu
hla
allel
use
singl
antigen
bead
figur
right
panel
report
class
antigen
toward
igm
igg
reactiv
descend
order
includ
hla
allel
express
donor
note
asterisk
figur
well
sever
nondonor
specif
hla
allel
highest
reactiv
observ
toward
nondonor
specif
hla
allel
panel
hla
specif
igm
igg
ident
indic
origin
clone
next
assess
reactiv
clone
supernat
two
gener
autoantigen
doubl
strand
dna
dsdna
insulin
well
whole
protein
lysat
made
human
kidney
cell
line
use
elisa
seven
immort
clone
display
reactiv
one
gener
selfantigen
figur
howev
clone
display
highest
reactiv
self
clone
also
react
hla
mica
molecul
figur
clone
strongli
react
lysat
dsdna
insulin
wherea
clone
reactiv
dsdna
also
show
reactiv
insulin
result
provid
evid
clone
polyreact
ie
reactiv
broad
rang
antigen
relat
one
anoth
select
polyreact
clone
togeth
anoth
b
cell
clone
show
reactiv
dsdna
lysat
hlamica
molecul
well
nonreact
clone
analysi
depict
figur
supernat
clone
react
carcinoma
cell
line
compar
manner
selfreact
antibodi
develop
patient
autoimmun
verifi
monoclon
select
clone
analyz
sequenc
immunoglobulin
heavi
chain
variabl
region
pcr
amplif
clone
cdna
use
seri
forward
primer
correspond
immunoglobulin
heavi
chain
variabl
region
vh
famili
gener
uniqu
band
figur
analysi
pcr
product
reveal
singl
sequenc
distinct
rearrang
complementari
determin
region
clone
sequenc
clone
ident
germlin
segment
sequenc
clone
display
multipl
point
mutat
upstream
domain
figur
mutat
frequenc
clone
nucleic
acid
level
percentag
silent
mutat
figur
lower
panel
accumul
somat
mutat
variabl
region
rearrang
immunoglobulin
gene
hallmark
differenti
memori
b
cell
shown
figur
mutat
clone
cell
highli
express
consist
memori
phenotyp
wherea
clone
figur
also
verifi
immort
clone
origin
recipi
shown
figur
clone
express
molecul
mismatch
hla
class
allel
recipi
donor
explant
kidney
graft
rel
frequenc
polyreact
clone
patient
graft
blood
assess
use
molecular
strategi
approach
consist
screen
larg
number
pcr
amplifi
vh
sequenc
hybrid
specif
probe
detect
quantifi
sequenc
correspond
b
cell
clone
approxim
sequenc
correspond
vh
famili
gener
pcr
use
rna
extract
graft
tissu
first
screen
clone
use
dot
blot
techniqu
figur
none
clone
could
detect
data
shown
techniqu
carri
rna
extract
patient
blood
posit
signal
correspond
sequenc
clone
could
found
indic
either
absent
patient
blood
repres
low
frequenc
contrast
clone
sequenc
detect
high
frequenc
among
sequenc
sinc
approxim
human
b
cell
use
segment
estim
frequenc
blood
b
cell
high
frequenc
reveal
clone
undergon
vigor
clonal
expans
vivo
consist
memori
phenotyp
accumul
somat
mutat
rearrang
immunoglobulin
heavi
chain
gene
fact
clone
found
high
frequenc
blood
graft
strongli
suggest
immort
residu
blood
cell
explant
kidney
tissu
examin
contribut
polyreact
antibodi
secret
high
frequenc
clone
reactiv
patient
serum
hla
class
molecul
self
antigen
depict
figur
multipl
hla
class
allel
recogn
patient
serum
month
month
post
transplant
includ
donor
specif
allel
serum
also
react
sever
nondonor
specif
hla
class
molecul
includ
recogn
clone
figur
seven
class
allel
toward
serum
react
month
posttranspl
also
recogn
monoclon
antibodi
figur
red
histogram
figur
moreov
serum
also
reactiv
cell
dsdna
insulin
antibodi
produc
clone
figur
correspond
serum
reactiv
pattern
clone
togeth
observ
clone
highli
expand
blood
strongli
suggest
antibodi
produc
present
serum
contribut
overal
reactiv
antibodi
key
element
host
respons
solid
organ
graft
involv
acut
chronic
form
reject
commonli
accept
antibodi
either
alloreact
ie
reactiv
polymorph
antigen
dispar
donor
recipi
donor
hla
molecul
autoreact
ie
recogn
selfdetermin
vimentin
myosin
distinct
alloand
autoreact
well
entrench
seldom
question
reli
assumpt
antibodi
specif
singl
antigen
self
nonself
describ
anoth
sort
antibodi
detect
amidst
kidney
graft
reject
neither
alloreact
autoreact
rather
polyreact
react
broad
rang
antigen
dissimilar
nucleic
acid
hla
molecul
antibodi
crossreact
multipl
hla
allel
alreadi
report
transplant
recipi
propos
recogn
public
epitop
share
among
polymorph
hla
allel
likewis
monoclon
antibodi
secret
immort
b
cell
clone
recogn
sever
hla
class
molecul
luminex
base
assay
howev
reactiv
pattern
exce
sole
recognit
public
hla
epitop
also
react
dna
cell
cytoplasm
structur
hek
protein
lysat
fact
patient
serum
react
nondonor
specif
hla
molecul
recogn
clone
togeth
demonstr
clone
highli
expand
blood
suggest
polyreact
antibodi
contribut
serum
reactiv
remark
reactiv
donor
allel
recogn
polyreact
antibodi
repres
small
compon
overal
serum
reactiv
plausibl
addit
high
frequenc
polyreact
clone
produc
antibodi
target
hla
molecul
includ
donor
specif
allel
toward
serum
reactiv
point
howev
discrimin
compon
serum
result
monospecif
polyreact
antibodi
recent
report
increas
serum
reactiv
wide
varieti
selfantigen
patient
undergo
chr
light
present
studi
observ
ration
explain
presenc
polyreact
antibodi
addit
studi
warrant
extend
find
transplant
recipi
patient
determin
exact
contribut
polyreact
b
cell
antibodi
produc
humor
respons
posttranspl
particular
circul
polyreact
antibodi
could
explain
detect
ndsa
even
high
panel
reactiv
antibodi
pra
measur
often
observ
transplant
recipi
graft
reject
reason
polyreact
igg
develop
chr
still
unclear
polyreact
igm
known
natur
igm
commonli
observ
healthi
individu
thought
produc
b
cell
review
experi
demonstr
unexpectedli
high
frequenc
clone
blood
patient
ongo
reject
frequenc
impli
consider
expans
vivo
consist
accumul
somat
mutat
found
immunoglobulin
heavi
chain
region
well
express
memori
marker
correspond
immort
b
cell
clone
hypothes
clone
uniqu
rather
repres
discret
subset
memori
somat
mutat
polyreact
b
cell
produc
natur
igm
physiolog
condit
upon
activ
context
inflamm
associ
graft
reject
result
common
infect
relat
immunosuppress
polyreact
b
cell
would
expand
undergo
class
switch
recombin
produc
igg
remark
clone
underw
class
switch
recombin
vitro
produc
igm
igg
cultur
supernat
although
like
result
ebv
immort
stimul
cpg
reveal
capac
cell
expand
undergo
class
switch
recombin
secret
antibodi
upon
stimul
import
question
whether
immort
cultur
condit
would
skew
b
cell
popul
exampl
differenti
stage
isol
b
cell
could
affect
abil
transform
address
critic
issu
carri
seri
immort
test
transit
memori
b
cell
sort
healthi
donor
sampl
immort
rate
compar
subset
show
signific
bia
would
introduc
immort
process
moreov
percentag
polyreact
b
cell
among
clone
consist
frequenc
polyreact
b
cell
describ
group
michel
nussenzweig
show
use
molecular
approach
percentag
polyreact
b
cell
contain
b
cell
review
polyreact
antibodi
describ
mani
year
especi
first
line
defens
bacteri
infect
implic
humor
respons
solid
organ
graft
howev
examin
warrant
addit
mechanist
studi
determin
whether
play
activ
role
tissu
destruct
whether
product
antibodi
consequ
graft
dysfunct
case
also
possibl
play
benefici
role
particip
mechan
wound
heal
overal
provid
proof
principl
exist
polyreact
human
monoclon
immunoglobulin
react
multipl
hla
allel
well
dna
self
structur
also
found
polyreact
antibodi
produc
memori
somat
mutat
b
cell
clone
highli
expand
blood
kidney
transplant
recipi
experienc
graft
reject
investig
advanc
knowledg
neglect
element
b
cell
immun
follow
solid
organ
transplant
precis
contribut
pathophysiolog
graft
reject
refer
web
version
pubm
central
supplementari
materi
reactiv
immort
b
cell
clone
hla
mica
molecul
reactiv
hla
mica
molecul
immort
b
cell
clone
measur
luminex
hla
mix
bead
kit
use
clone
supernat
antiigg
antiigm
secondari
antibodi
upper
lower
panel
respect
clone
supernat
contain
igg
igm
anticlass
antibodi
test
luminex
use
class
singl
antigen
bead
class
allel
toward
antibodi
react
depict
right
panel
result
present
normal
fold
increas
compar
control
uncoat
bead
hla
class
allel
express
donor
mark
asterisk
reactiv
immort
b
cell
clone
selfantigen
reactiv
b
cell
clone
toward
gener
self
antigen
dsdna
insulin
well
toward
whole
protein
lysat
prepar
kidney
cell
line
measur
elisa
result
present
normal
fold
increas
compar
refer
valu
b
reactiv
select
immort
clonal
supernat
permeabil
cell
stain
cell
reveal
use
fitcconjug
antiiggm
secondari
antibodi
pictur
acquir
use
set
consist
purpos
b
cell
clone
frequenc
blood
frequenc
polyreact
clone
assess
blood
hybrid
plasmid
clone
pcr
amplifi
vh
segment
use
dot
blot
assay
describ
figur
bacteri
coloni
grown
well
micropl
transfer
onto
membran
screen
correspond
clonotyp
probe
figur
ten
membran
screen
clone
upper
left
corner
dot
plate
contain
control
plasmid
posit
dot
analyz
verifi
presenc
uniqu
clonal
sequenc
weakli
posit
dot
observ
fals
posit
membran
also
screen
presenc
vh
sequenc
use
consensu
jh
probe
ratio
posit
clonotyp
sequenc
total
vh
sequenc
report
clone
patient
serum
reactiv
reactiv
patient
serum
igg
hla
class
molecul
test
luminex
allel
toward
serum
reactiv
depict
time
point
post
transplant
class
allel
toward
clone
reactiv
depict
red
bar
class
allel
express
donor
label
asterisk
b
patient
serum
igg
reactiv
cell
determin
use
sampl
collect
time
transplant
nephrectomi
month
posttranspl
serum
repres
nonchr
patient
use
control
stain
reveal
use
fitcconjug
antiigg
secondari
c
serum
reactiv
self
antigen
patient
serum
collect
month
posttransplant
assess
reactiv
dsdna
insulin
elisa
serum
sampl
collect
non
chr
patient
use
control
reactiv
reveal
use
hrpconjug
antiigg
secondari
antibodi
